Fenofibrate Zydus

Fenofibrate (Nanonised) by Zydus France is a medication used to manage cholesterol levels and support cardiovascular health. This oral medication is designed to help reduce triglycerides and increase HDL cholesterol.

Fenofibrate (Nanonised) is primarily used to lower triglyceride levels in the blood. It is often prescribed for individuals with high cholesterol or those at risk of cardiovascular diseases. This medication works by reducing the production of triglycerides in the liver, helping to improve lipid profiles and support heart health.

Common effects of Fenofibrate (Nanonised) may include gastrointestinal discomfort, such as nausea or diarrhea. Some users might experience muscle pain or weakness. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Fenofibrate (Nanonised) should be used with caution in individuals with liver or kidney disease. It is important to follow the prescribed dosage and avoid alcohol consumption while taking this medication. Regular monitoring of liver function may be recommended.

Fenofibrate (Nanonised) may interact with other medications, including blood thinners and certain cholesterol-lowering drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.